Brandie Laurel Walker is a Canadian physician and medical researcher based in Calgary, Alberta.[1] She is the respiratory representative on the AHS COVID-19 Scientific Advisory Group under Alberta Health Services.[2] She is a clinical associate professor of medicine at the University of Calgary's Snyder Institute for Chronic Diseases.[3]
Her research focus is in the field of airways diseases with a focus on COPD and asthma.
Career
Walker is a researcher for the Canadian Lung Association. She received the Clinician-Scientist Asthma Award, which provided her with $115,000.00 in funding from AllerGen, the Canadian Lung Association and the Canadian Thoracic Society.[4]
She is the Calgary site principal investigator for the Canadian Cohort Obstructive Lung Disease (CanCOLD) study.[5]
External links
Dr. Brandie Laurel Walker. Calgary Doctors Directory. Retrieved January 8, 2025, from https://www.calgarydoctors.org/alberta/calgary/internal-medicine-specialist/dr-brandie-laurel-walker ↩︎
2019-nCoV Scientific Advisory Group. (2021, May 27). Alberta Health Services. https://www.albertahealthservices.ca/assets/info/ppih/if-ppih-covid-19-sag-terms-of-reference.pdf ↩︎
Brandie Walker. Snyder Institute for Chronic Diseases. Retrieved January 9, 2022, from http://archive.vn/2022.01.09-211000/https://snyder.ucalgary.ca/profiles/dr-Brandie-Walker ↩︎
Dr. Brandie Walker. (2016, December 10). Canadian Lung Association. http://archive.vn/2022.01.09-211927/https://www.lung.ca/lung-research/our-researchers/dr-brandie-walker ↩︎
Canadian Cohort Obstructive Lung Disease (CanCOLD). Research Institute of the McGill University Health Centre. Retrieved September 9, 2024, from https://web.archive.org/web/20240909142213/https://rimuhc.ca/research-initiatives/cancold ↩︎
